Increased membrane-associated nucleoside diphosphate kinase activity as a possible basis for enhanced guanine nucleotide-dependent adenylate cyclase activity induced by picolinic acid treatment of simian virus 40-transformed normal rat kidney cells.
A biochemical analysis of an increase in guanine nucleotide-dependent adenylate cyclase activity induced by treatment of cultured SV40-transformed normal rat kidney cells with picolinic acid is described. In purified membranes from drug-treated cells with an ATP regenerating system in assay, GTP- and GTP plus hormone-stimulated adenylate cyclase activities were increased, whereas basal and NaF-stimulated cyclase activities, and steady state rate with guanosine 5'-(beta, gamma-imino)triphosphate were essentially unaltered by drug treatment. In assay systems devoid of ATP regenerating system, the drug-induced increase in cyclase activity was seen with GDP as well as with GTP, it being larger with GDP than with GTP in terms of activity ratio, whereas such an increase was not observed with their analogs, guanosine 5'-O-(2-thiodiphosphate) or guanosine 5'-(beta, gamma-imino)triphosphate. Guanosine 5'-(beta, gamma-imino)triphosphate-stimulated from drug-treated membranes became less sensitive to the inhibition by GDP as shown by a rightward shift in inhibition curve, but this shift could not be reproduced with guanosine 5'-O-(2-thiodiphosphate). From these results, it was concluded that altered guanine nucleotide metabolism in membranes was involved. Neither the amount of guanine nucleotide-binding protein nor its related functions including GTPase activity were changed by drug treatment. However, we observed in the drug-treated cell membranes, an increase in activity of nucleoside diphosphate kinase, an additional factor which has been proposed to play a role in regulating adenylate cyclase by replenishing GTP near the guanine nucleotide binding site (Kimura, N., and Shimada, N. (1983) J. Biol. Chem. 258, 2278-2283). The altered features of adenylate cyclase with the natural guanine nucleotides induced by drug treatment were explained as a result of this enhanced nucleoside diphosphate kinase activity associated with the membranes.
D000262:Adenylyl Cyclases / Q000235:genetics*; D000527:Alprostadil; D000818:Animals; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D002472:Cell Transformation, Viral / Q000187:drug effects*; D002772:Cholera Toxin / Q000494:pharmacology; D004790:Enzyme Induction; D019204:GTP-Binding Proteins; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007668:Kidney; D009701:Nucleoside-Diphosphate Kinase / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*; D010848:Picolinic Acids / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000235:genetics*; D013539:Simian virus 40 / Q000235:genetics*; D012969:Sodium Fluoride / Q000494:pharmacology
D010848:Picolinic Acids; D011458:Prostaglandins E; D011956:Receptors, Cell Surface; D006165:Guanylyl Imidodiphosphate; D012969:Sodium Fluoride; D002772:Cholera Toxin; D010770:Phosphotransferases; D009701:Nucleoside-Diphosphate Kinase; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D000527:Alprostadil; C030614:picolinic acid